Efficacy and Safety of Low-Dose Everolimus as Maintenance Immunosuppression in Cardiac Transplant Recipients

For cardiac transplant (CTx) recipients, the recommended everolimus (EVL) dose is 0.75 mg bid or 1.5 mg bid and the target trough blood level is 3–8 μg/L. We studied a cohort of 56 CTx patients with chronic kidney disease receiving 0.75 mg bid EVL to maintain blood levels of 5–8 ug/L (designated RD...

Descripción completa

Detalles Bibliográficos
Autores principales: Fuchs, Uwe, Zittermann, Armin, Schulz, Uwe, Gummert, Jan F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345239/
https://www.ncbi.nlm.nih.gov/pubmed/22577516
http://dx.doi.org/10.1155/2012/976921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3345239/
https://www.ncbi.nlm.nih.gov/pubmed/22577516
http://dx.doi.org/10.1155/2012/976921

Ejemplares similares